Lloyd Mitchell Segal - 28 Jun 2021 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Role
President and CEO
Signature
/s/ Steve Forte, Attorney-in-Fact
Issuer symbol
RPTX
Transactions as of
28 Jun 2021
Net transactions value
-$54,911
Form type
4
Filing time
30 Jun 2021, 17:54:48 UTC
Previous filing
10 Jun 2021
Next filing
20 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPTX Common Stock Sale $54,911 -1,542 -1.6% $35.61 94,466 28 Jun 2021 See footnote F1, F2
holding RPTX Common Stock 5,000 28 Jun 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 31, 2020.
F2 These securities are registered in the name of Arvala Inc. (f/k/a 3996953 Canada Inc., the "Company"). The Reporting Person is the sole stockholder of the Company.